A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)
Long Term Outcomes Associated With Attainment of Remission Following Oral Immunotherapy to Peanut, Egg and Cow's Milk (LPEM Study)
Murdoch Childrens Research Institute
147 participants
Jan 13, 2026
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to learn about the long-term outcomes of children and young people who underwent an 18-month course of oral immunotherapy (OIT) treatment for peanut, egg or milk allergy. It aims to: • Compare long-term changes in health-related quality of life (HRQL) at 5-15 years after stopping OIT in participants who achieved remission and those who did not. Participants will attend a single follow-up visit for: * A blood test * Skin prick test (SPT) * Allergy questionnaires
Eligibility
Inclusion Criteria3
- Previous participant of PEAT, PrEMO, PPOIT-001 or PPOIT-002 parent study
- Received at least one dose of OIT treatment in the parent study
- Written informed consent from participant and/or parent/guardian (if below 18 years of age)
Exclusion Criteria1
- Have any conditions that, in the opinion of the investigator, precludes participation for reason of safety
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07359183